Defined microbial communities and their soluble products protect mice from Clostridioides difficile infection
Abstract Clostridioides difficile is the leading cause of antibiotic-associated infectious diarrhea. The development of C.difficile infection is tied to perturbations of the bacterial community in the gastrointestinal tract, called the gastrointestinal microbiota. Repairing the gastrointestinal micr...
Principais autores: | Katya Douchant, Shu-Mei He, Curtis Noordhof, Jill Greenlaw, Sarah Vancuren, Kathleen Schroeter, Emma Allen-Vercoe, Calvin Sjaarda, Stephen J. Vanner, Elaine O. Petrof, Prameet M. Sheth, Mabel Guzman |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Nature Portfolio
2024-01-01
|
coleção: | Communications Biology |
Acesso em linha: | https://doi.org/10.1038/s42003-024-05778-6 |
Registros relacionados
-
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
por: Christian Carlucci, et al.
Publicado em: (2016-11-01) -
Small-molecule metabolome identifies potential therapeutic targets against COVID-19
por: Sean Bennet, et al.
Publicado em: (2022-06-01) -
The gut-brain axis and beyond: Microbiome control of spinal cord injury pain in humans and rodents
por: Courtney A. Bannerman, et al.
Publicado em: (2021-01-01) -
Editorial: Clostridioides difficile infection
por: Guido Granata, et al.
Publicado em: (2024-02-01) -
Pathogenicity and virulence of Clostridioides difficile
por: Jessica E. Buddle, et al.
Publicado em: (2023-12-01)